Getein Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	256.8	313.88	351.6	484.33	646.25	968.9
Trading Asset Securities	1,101	912.63	648.88	451.91	511.14	612.68
Cash & Short-Term Investments	1,358	1,227	1,000	936.24	1,157	1,582
Cash Growth	55.90%	22.59%	6.86%	-19.11%	-26.82%	13.26%
Accounts Receivable	327.79	360.5	359.65	453.18	502.1	445.96
Other Receivables	27.3	31.45	50.29	133.31	37.36	37.45
Receivables	355.09	391.95	409.94	586.49	539.45	483.41
Inventory	195.88	183.83	194.46	229.71	269.39	252.3
Other Current Assets	409.57	500.39	252.18	398.75	433.12	48.13
Total Current Assets	2,318	2,303	1,857	2,151	2,399	2,365
Property, Plant & Equipment	722.53	724.05	707.48	703.86	556.49	452.2
Long-Term Investments	139.3	219.52	889.75	641.21	223.6	142.86
Goodwill	12.02	12.02	0.31	26.14	26.14	26.14
Other Intangible Assets	168.53	172.94	141.55	113.79	103.91	77.21
Long-Term Accounts Receivable	-	-	4.9	8.23	9.25	10.93
Long-Term Deferred Tax Assets	60.93	57.83	47.89	43.18	35.48	14.92
Long-Term Deferred Charges	32.74	31.49	55.07	80.12	51.05	43.68
Other Long-Term Assets	244.44	235.41	3.39	3.92	273.63	4.56
Total Assets	3,699	3,756	3,707	3,772	3,679	3,138
Accounts Payable	173.7	190.15	77.4	73.73	102.95	110.97
Accrued Expenses	54.87	64.34	98.39	103.03	120.22	85
Short-Term Debt	399.81	479.89	575.57	641.29	551.94	464.37
Current Portion of Long-Term Debt	-	0.77	-	12.89	25.8	0.2
Current Portion of Leases	-	-	4.38	9.79	5.63	2.1
Current Income Taxes Payable	-	25.62	12.2	9.58	9.04	10.48
Current Unearned Revenue	40.05	39.35	34.87	38.17	75.37	94.29
Other Current Liabilities	53.94	55.05	137.22	90.91	67.12	46.08
Total Current Liabilities	722.36	855.17	940.01	979.38	958.06	813.48
Long-Term Debt	-	-	-	-	3	27.78
Long-Term Leases	1.22	1.3	1.62	2.71	4.65	2
Long-Term Unearned Revenue	15.07	15.71	18.3	20.88	23.47	5.87
Long-Term Deferred Tax Liabilities	27.03	24.37	26.48	27.41	24.2	13.96
Other Long-Term Liabilities	-	-	-	-	0.91	0.8
Total Liabilities	765.68	896.55	986.42	1,030	1,014	863.9
Common Stock	507.15	507.15	507.15	507.15	507.15	363.81
Additional Paid-In Capital	-	236.9	236.18	314.01	318.24	511.58
Retained Earnings	2,071	1,995	1,865	1,732	1,655	1,280
Treasury Stock	-	-	-	-	-	-50
Comprehensive Income & Other	251.28	13.84	10.16	5.87	1.69	1.37
Total Common Equity	2,830	2,753	2,619	2,559	2,482	2,106
Minority Interest	103.58	106.65	101.99	181.92	182.13	167.63
Shareholders' Equity	2,933	2,859	2,721	2,741	2,665	2,274
Total Liabilities & Equity	3,699	3,756	3,707	3,772	3,679	3,138
Total Debt	401.03	481.96	581.57	666.68	591.02	496.44
Net Cash (Debt)	956.8	744.54	418.9	269.56	566.37	1,085
Net Cash Growth	257.52%	77.74%	55.40%	-52.41%	-47.81%	7.27%
Net Cash Per Share	1.89	1.48	0.82	0.53	1.11	2.12
Filing Date Shares Outstanding	508.69	500.91	507.15	507.15	507.15	507.15
Total Common Shares Outstanding	508.69	500.91	507.15	507.15	507.15	507.15
Working Capital	1,596	1,448	917.03	1,172	1,441	1,552
Book Value Per Share	5.56	5.50	5.16	5.05	4.89	4.15
Tangible Book Value	2,649	2,568	2,477	2,419	2,352	2,003
Tangible Book Value Per Share	5.21	5.13	4.88	4.77	4.64	3.95
Buildings	-	-	273.29	247.34	243.57	240.18
Machinery	-	-	527.67	529.3	440.02	296.94
Construction In Progress	-	-	225.08	205.76	86.37	80.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.